Soma Pharmacy Blognews

1 Swine Flu Shot Enough?
One swine flu shot may be all adults need for immunity against the pandemic H1N1 swine flu virus.

More Americans Have No Health Insurance
The number of Americans without health insurance rose slightly to 46.3 million in 2008.

Give Kids First Shot at Swine Flu Vaccine?
An all-out vaccination program that targets children first could mitigate the impact of an expected H1N1 swine flu pandemic this fall, new research indicates.

Obama’s Health Plan: The Debate Goes On
Experts react to President Obama’s speech on health reform before a joint session of Congress.

Day Care Doesn’t Protect Against Asthma
Infants and toddlers who attend day care are no less likely to develop asthma symptoms later in childhood than those who don’t, new research shows.

Galapagos Initiates Second Phase I Clinical Trial For GLPG0259
Second trial, an extension of the positive outcome of the first-in-human trial earlier in 2009

Phase 2b clinical trial results of TC-5214 to be presented at nAChR2009
Targacept, Inc., a clinical-stage biopharmaceutical company developing a new class of drugs known as NNR Therapeutics, today confirmed plans to present data from its completed Phase 2b clinical trial of TC-5214 as an augmentation treatment for major depressive disorder at the Nicotinic Acetylcholine Receptors [...]

FDA approves Supplemental New Drug Application for DOXIL
Centocor Ortho Biotech Products, L.P. today announced that it received a Complete Response letter from the U.S. Food and Drug Administration (FDA) regarding its Supplemental New Drug Application (sNDA) for DOXIL (doxorubicin HCI liposome injection) in combination with docetaxel for the treatment of women with locally advanced and [...]

FDA removes clinical hold on HEPLISAV hepatitis B vaccine
Dynavax Technologies Corporation today announced that the U.S. Food and Drug Administration (FDA) has removed the clinical hold for the HEPLISAVTM Investigational New Drug (IND) application in individuals with chronic kidney disease.

Hypercholesterolemia therapy area pipeline report from Research and Markets
Research and Markets (http://www.researchandmarkets.com/research/9f0a24/hypercholesterolem) has announced the addition of the “Hypercholesterolemia Therapy Area Pipeline Report” report to their offering.